Trial Details
COMPLETEDBasic Information
| Clinical ID | c4639 |
|---|---|
| Identifier | NCT00215566 |
| Trial Title | A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome With Constipation|Irritable Bowel Syndrome |
| Interventions | DRUG: DDP733 |
Participant Information
| Sponsor | Dynogen Pharmaceuticals |
|---|---|
| City | Alberta |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2005-09 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |